Tae Hyun Hwang, Ph.D.
Professor, Surgical Research
Founding Director, Molecular AI Initiative
Director, AI Research in Surgical Sciences
Our goal is to improve cancer patient outcomes by integrating artificial intelligence (AI), machine learning, computational methods, and experimental approaches. Our interdisciplinary research spans spatial biology, single-cell analysis, digital pathology, biomarker discovery, spatial microbiome analysis, and therapeutic development, including immunotherapy and cellular therapies.
We develop AI-driven 3D and 4D tumor models to investigate the complex interactions between cellular, molecular, and microbiome components. This approach enables the identification of novel biomarkers, therapeutic targets, and personalized treatment strategies. By integrating advanced technologies, the Hwang Lab advances personalized medicine, with a focus on the tumor immune microenvironment (TIME), ultimately benefiting cancer patients.